Year To Quarter End Consolidated Statement Of Income

COSMO BIO COMPANY, LIMITED - Filing #7312916

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Year to quarter end consolidated statement of income
Statement of income
Net sales
5,129,000,000 JPY
4,827,000,000 JPY
Cost of sales
3,416,000,000 JPY
3,062,000,000 JPY
Gross profit (loss)
1,712,000,000 JPY
1,765,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
1,389,000,000 JPY
1,306,000,000 JPY
Operating profit (loss)
322,000,000 JPY
458,000,000 JPY
Non-operating income
Interest income
4,000,000 JPY
3,000,000 JPY
Dividend income
34,000,000 JPY
31,000,000 JPY
Non-operating income
47,000,000 JPY
101,000,000 JPY
Non-operating expenses
Interest expenses
0 JPY
0 JPY
Non-operating expenses
33,000,000 JPY
8,000,000 JPY
Ordinary profit (loss)
337,000,000 JPY
552,000,000 JPY
Extraordinary income
Extraordinary income
53,000,000 JPY
JPY
Profit (loss) before income taxes
390,000,000 JPY
552,000,000 JPY
Income taxes
123,000,000 JPY
174,000,000 JPY
Profit (loss)
267,000,000 JPY
377,000,000 JPY
Profit attributable to
Profit (loss) attributable to non-controlling interests
8,000,000 JPY
16,000,000 JPY
Profit (loss) attributable to owners of parent
258,000,000 JPY
361,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
519,000,000 JPY
161,000,000 JPY
Deferred gains or losses on hedges
17,000,000 JPY
9,000,000 JPY
Foreign currency translation adjustment
26,000,000 JPY
17,000,000 JPY
Other comprehensive income
563,000,000 JPY
188,000,000 JPY
Comprehensive income
830,000,000 JPY
565,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
821,000,000 JPY
549,000,000 JPY
Comprehensive income attributable to non-controlling interests
8,000,000 JPY
16,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.